docetaxel · Hospira Inc · NDA 022234, 022312, 022534, 201195, 201525, 202356, 203551, 205934
Docetaxel
9 of 12 marketed strengths have no unexpired patent or exclusivity listed.
Blocked by patent: US 8940786, US 9308195, US 9763880.
Listed patents · 4 unexpired
10 Orange Book listing rows for 4 patents. FDA lists a patent once for each use code, and lists its pediatric extension as a separate row.
| Patent | Claims | Expires |
|---|---|---|
| US 8940786 | drug product, use U-1789 · sets the listed date | 30 Sep 2033 |
| US 9308195 | drug product · sets the listed date | 30 Sep 2033 |
| US 9763880 | use U-2558, U-2559, U-2560, U-2561, U-2562, U-2563, U-2564 | 30 Sep 2033 |
| US 9763880 listing row | use U-2558 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2559 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2560 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2561 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2562 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2563 · sets the listed date | 30 Sep 2033 |
| US 9763880 listing row | use U-2564 · sets the listed date | 30 Sep 2033 |
| US 10842770 | drug product, use U-2998 | 7 Aug 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 31
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022234 · 001 · RLD | injectable, injection | 20MG/2ML (10MG/ML) | open |
| 022234 · 002 · RLD | injectable, injection | 80MG/8ML (10MG/ML) | open |
| 022234 · 003 · RLD | injectable, injection | 160MG/16ML (10MG/ML) | open |
| 022234 · 004 · RLD | injectable, injection | 20MG/ML (20MG/ML) | open |
| 022234 · 005 · RLD | injectable, injection | 80MG/4ML (20MG/ML) | open |
| 022234 · 006 · RLD · discontinued | injectable, injection | 120MG/6ML (20MG/ML) | open |
| 022234 · 007 · RLD | injectable, injection | 160MG/8ML (20MG/ML) | open |
| 022312 · 001 · discontinued | injectable, injection | 20MG/0.5ML (40MG/ML) | open |
| 022312 · 002 · discontinued | injectable, injection | 80MG/2ML (40MG/ML) | open |
| 022534 · 003 · discontinued | injectable, injection | 20MG/ML (20MG/ML) | open |
| 022534 · 004 · discontinued | injectable, injection | 80MG/4ML (20MG/ML) | open |
| 022534 · 005 · discontinued | injectable, injection | 160MG/8ML (20MG/ML) | open |
| 201195 · 001 · RLD · discontinued | injectable, injection | 20MG/0.5ML (40MG/ML) | open |
| 201195 · 002 · RLD · discontinued | injectable, injection | 80MG/2ML (40MG/ML) | open |
| 201195 · 003 · RLD | injectable, injection | 20MG/ML (20MG/ML) | open |
| 201195 · 004 · RLD | injectable, injection | 80MG/4ML (20MG/ML) | open |
| 201195 · 005 · RLD | injectable, injection | 160MG/8ML (20MG/ML) | open |
| 201525 · 001 | injectable, injection | 20MG/2ML (10MG/ML) | open |
| 201525 · 002 | injectable, injection | 80MG/8ML (10MG/ML) | open |
| 201525 · 003 | injectable, injection | 160MG/16ML (10MG/ML) | open |
| 202356 · 001 · discontinued | injectable, injection | 20MG/2ML (10MG/ML) | open |
| 202356 · 002 · discontinued | injectable, injection | 80MG/8ML (10MG/ML) | open |
| 202356 · 003 · discontinued | injectable, injection | 130MG/13ML (10MG/ML) | open |
| 202356 · 004 · discontinued | injectable, injection | 200MG/20ML (10MG/ML) | open |
| 203551 · 001 | injectable, injection | 20MG/ML (20MG/ML) | open |
| 203551 · 002 | injectable, injection | 80MG/4ML (20MG/ML) | open |
| 203551 · 003 | injectable, injection | 140MG/7ML (20MG/ML) | open |
| 203551 · 004 | injectable, injection | 160MG/8ML (20MG/ML) | open |
| 205934 · 001 · RLD | injectable, injection | 20MG/ML (20MG/ML) | 30 Sep 2033 |
| 205934 · 002 · RLD | injectable, injection | 80MG/4ML (20MG/ML) | 30 Sep 2033 |
| 205934 · 003 · RLD | injectable, injection | 160MG/8ML (20MG/ML) | 30 Sep 2033 |